Canadian companies are targeting a demographic beyond casual pot users by developing marijuana-based medicines in pill and inhaler form. The CEO of Scientus Pharma says their target market likely doesn’t have experience smoking weed. (March 15)
The Canadian Press is Canada’s most trusted news leader in providing real-time, bilingual multimedia content for online, mobile and emerging platforms.
